Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Beneficial effects of short-term erythropoietin (EPO) therapy have been demonstrated in several animal models of acute neurologic injury, including experimental autoimmune encephalomyelitis (EAE)--the animal model of multiple sclerosis. We have found that EPO treatment substantially reduces the acute clinical paralysis seen in EAE mice and this improvement is accompanied by a large reduction in the mononuclear cell infiltration and downregulation of glial MHC class II expression within the inflamed CNS. Other reports have recently indicated that peripherally generated anti-inflammatory CD4(+)Foxp3(+) regulatory T cells (Tregs) and the IL17-producing CD4+ T helper cell (Th17) subpopulations play key antagonistic roles in EAE pathogenesis. However, no information regarding the effects of EPO therapy on the behavior of the general mononuclear-lymphocyte population, Tregs or Th17 cells in EAE has emerged. METHODS AND FINDINGS: We first determined in vivo that EPO therapy markedly suppressed MOG specific T cell proliferation and sharply reduced the number of reactive dendritic cells (CD11c positive) in EAE lymph nodes during both inductive and later symptomatic phases of MOG(35-55) induced EAE. We then determined the effect in vivo of EPO on numbers of peripheral Treg cells and Th17 cells. We found that EPO treatment modulated immune balance in both the periphery and the inflamed spinal cord by promoting a large expansion in Treg cells, inhibiting Th17 polarization and abrogating proliferation of the antigen presenting dendritic cell population. Finally we utilized tissue culture assays to show that exposure to EPO in vitro similarly downregulated MOG-specific T cell proliferation and also greatly suppressed T cell production of pro-inflammatory cytokines. CONCLUSIONS: Taken together, our findings reveal an important new locus whereby EPO induces substantial long-term tissue protection in the host through signaling to several critical subsets of immune cells that reside in the peripheral lymphatic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This cytokine rise coincided with the decline in serum erythropoietin and, in the setting of hemoglobin levels and renal function similar to those of the other patients, may have indicated that erythropoietin was immunomodulatory in this setting [37, 38].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“maintenance of peripheral tolerance and in controlling the destructive self-reactive T cells found in autoimmune animal models of arthritis, multiple sclerosis, diabetes, and inflammatory bowel disease [10,11,12].”
BackgroundSakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 1×
“Antiinflammatory regulatory T cells have been found to be an important CD4 cell subpopulation for controlling the development of autoimmune disease [12,34,35,36,37,38].”
BackgroundLoss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856 · cited 1×
“Antiinflammatory regulatory T cells have been found to be an important CD4 cell subpopulation for controlling the development of autoimmune disease [12,34,35,36,37,38].”
BackgroundRegulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,820 · cited 1×
“and inflammatory bowel disease [26,27,28,29].”
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402 · cited 1×
“Beneficial therapeutic effects of exogenously administered whole molecule EPO have been described in several animal models of neurologic injury, including occlusive cerebral vascular disease, acute brain trauma, epilepsy, as well as in both autoimmune arthritis and EAE [14,45,46].”
BackgroundSutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010 · cited 1×
“inflammation [5,6,7,8,9].”
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811 · cited 2×
“Mononuclear cells from the spinal cord were isolated following a published protocol by Korn T et al [54].”
MethodDerivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803 · cited 1×
“Other EPO molecular preparations, such as an asialo-form of EPO, carbamylated EPO (CEPO), or certain EPO mutants, have been reported to have protective effects in animals following experimental traumatic spinal cord injury or acute stroke without provoking an increase in red cell mass [47,48,49].”
BackgroundKohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Differentiation and function of Th17 T cells
Stockinger, B., & Veldhoen, M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.005 · Cited by 721 · cited 1×
“inflammation [5,6,7,8,9].”
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 701 · cited 1×
“and inflammatory bowel disease [26,27,28,29].”
Leyland-Jones, B., Semiglazov, V., Pawlicki, M., Pienkowski, T., Tjulandin, S., Manikhas, G., Makhson, A., Roth, A., Dodwell, D., Baselga, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.150 · Cited by 668 · cited 1×
“. A large clinical trial, the breast cancer erythropoietin survival trial (BEST) was terminated early because of an increased number of patients experiencing early demise in the EPO arm”
BackgroundA Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 659 · cited 1×
“EAE is a commonly studied animal model of acute central nervous system inflammatory demyelinating disease, and it is believed that autoreactive T cells and proinflammatory cytokines play key roles in the early inductive phase and later paralytic stages of EAE pathogenesis [16,30,31].”
BackgroundBrines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.-W., Smart, J., Su-Rick, C.-J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406491101 · Cited by 656 · cited 1×
“The common beta receptor is used for IL-5, IL-3, and macrophage colony stimulating factor signaling and is upregulated during inflammatory responses [44] .”
BackgroundChen, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25308 · Cited by 555 · cited 1×
“These animals have greatly expanded dendritic cell populations; show exaggerated immune responses and subsequently develop systemic autoimmunity [41,42,43].”
BackgroundSELECTION OF THE T CELL REPERTOIRE
Sebzda, E., Mariathasan, S., Ohteki, T., Jones, R., Bachmann, M. F., & Ohashi, P. S. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.829 · Cited by 495 · cited 1×
“tolerance [1,2].”
Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
Dong, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1807 · Cited by 487 · cited 1×
“inflammation [5,6,7,8,9].”
Hirota, K., Hashimoto, M., Yoshitomi, H., Tanaka, S., Nomura, T., Yamaguchi, T., Iwakura, Y., Sakaguchi, N., & Sakaguchi, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062259 · Cited by 482 · cited 1×
“Since IL-6 has been reported to promote differentiation of naı̈ve CD4 T cells into Th17 cells in vitro, the level of IL-6 secretion by inflammatory cells could be playing a crucial role for in vivo development and expansion of Th17 cells [40].”
BackgroundMyelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice
Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., & Raine, C. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7579 · Cited by 444 · cited 3×
“Traditionally CD4 T cells have been considered to be the critical element in EAE pathogenesis, but recent studies have indicated that CD8 cells may also play an important role in EAE induction and disease progression [16,17,18,30].”
BackgroundAsialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
Erbayraktar, S., Grasso, G., Sfacteria, A., Xie, Q.-W., Coleman, T., Kreilgaard, M., Torup, L., Sager, T., Erbayraktar, Z., Gokmen, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031753100 · Cited by 436 · cited 1×
“Other EPO molecular preparations, such as an asialo-form of EPO, carbamylated EPO (CEPO), or certain EPO mutants, have been reported to have protective effects in animals following experimental traumatic spinal cord injury or acute stroke without provoking an increase in red cell mass [47,48,49].”
BackgroundTherapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Weishaupt, A., Toyka, K. V., & Gold, R. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.11.002 · Cited by 423 · cited 1×
“and inflammatory bowel disease [26,27,28,29].”
Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.39 · Cited by 364 · cited 1×
“Since proinflammatory cytokines, especially IL-2, IL-6 and TNFa, play significant roles in EAE pathogenesis [20,21,33], we collected supernatants from either EPO or control media treated cell cultures and quantified levels of cytokines.”
MethodAgnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M. L., & Ghezzi, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03239-0 · Cited by 334 · cited 1×
“Erythropoietin (EPO), a 165 amino acid glycoprotein cytokine, has been used extensively for the treatment of anemia in humans and has been shown to have the capacity to induce neuroprotection in a disparate variety of animal models of nervous system disease [14,23,24,25].”
BackgroundStranges, P. B., Watson, J., Cooper, C. J., Choisy-Rossi, C.-M., Stonebraker, A. C., Beighton, R. A., Hartig, H., Sundberg, J. P., Servick, S., Kaufmann, G., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.016 · Cited by 334 · cited 1×
“These animals have greatly expanded dendritic cell populations; show exaggerated immune responses and subsequently develop systemic autoimmunity [41,42,43].”
BackgroundWekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H., & Linington, C. (1994) · Annals of Neurology · doi:10.1002/ana.410360714 · Cited by 292
Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
Brines, M., & Cerami, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001546 · Cited by 290 · cited 2×
“Erythropoietin (EPO), a 165 amino acid glycoprotein cytokine, has been used extensively for the treatment of anemia in humans and has been shown to have the capacity to induce neuroprotection in a disparate variety of animal models of nervous system disease [14,23,24,25].”
BackgroundAutoimmune inflammation from the Th17 perspective
Furuzawa-Carballeda, J., Vargas-Rojas, M. I., & Cabral, A. R. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.10.002 · Cited by 289 · cited 1×
“inflammation [5,6,7,8,9].”
Do Erythropoietin Receptors on Cancer Cells Explain Unexpected Clinical Findings?
Henke, M., Mattern, D., Pepe, M., Bézay, C., Weissenberger, C., Werner, M., & Pajonk, F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2737 · Cited by 240
Fujikado, N., Saijo, S., Yonezawa, T., Shimamori, K., Ishii, A., Sugai, S., Kotaki, H., Sudo, K., Nose, M., & Iwakura, Y. (2008) · Nature Medicine · doi:10.1038/nm1697 · Cited by 208 · cited 1×
“These animals have greatly expanded dendritic cell populations; show exaggerated immune responses and subsequently develop systemic autoimmunity [41,42,43].”
BackgroundReddy, J., Illes, Z., Zhang, X., Encinas, J., Pyrdol, J., Nicholson, L., Sobel, R. A., Wucherpfennig, K. W., & Kuchroo, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404444101 · Cited by 187 · cited 1×
“Antiinflammatory regulatory T cells have been found to be an important CD4 cell subpopulation for controlling the development of autoimmune disease [12,34,35,36,37,38].”
BackgroundT Lymphocyte Tolerance: From Thymic Deletion to Peripheral Control Mechanisms
Stockinger, B. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60404-6 · Cited by 159 · cited 1×
“tial still circulate in the peripheral lymphoid tissues [3,4].”
BackgroundKassiotis, G., Zamoyska, R., & Stockinger, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021812 · Cited by 159 · cited 1×
“tial still circulate in the peripheral lymphoid tissues [3,4].”
BackgroundFord, M. L., & Evavold, B. D. (2005) · European Journal of Immunology · doi:10.1002/eji.200425660 · Cited by 139 · cited 2×
“Traditionally CD4 T cells have been considered to be the critical element in EAE pathogenesis, but recent studies have indicated that CD8 cells may also play an important role in EAE induction and disease progression [16,17,18,30].”
BackgroundSteinman, L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.f27 · Cited by 114 · cited 3×
“Traditionally CD4 T cells have been considered to be the critical element in EAE pathogenesis, but recent studies have indicated that CD8 cells may also play an important role in EAE induction and disease progression [16,17,18,30].”
BackgroundReddy, J., Waldner, H., Zhang, X., Illes, Z., Wucherpfennig, K. W., Sobel, R. A., & Kuchroo, V. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5591 · Cited by 113 · cited 1×
“maintenance of peripheral tolerance and in controlling the destructive self-reactive T cells found in autoimmune animal models of arthritis, multiple sclerosis, diabetes, and inflammatory bowel disease [10,11,12].”
BackgroundBeneficial effect of erythropoietin on experimental allergic encephalomyelitis
Li, W., Maeda, Y., Yuan, R. R., Elkabes, S., Cook, S., & Dowling, P. (2004) · Annals of Neurology · doi:10.1002/ana.20274 · Cited by 102 · cited 9×
“EAE is a central nervous system inflammatory demyelinating disease of animals that attacks the spinal cord and brain white matter [13,14].”
BackgroundMethodInfluentialSelf-citationBynoe, M. S., Evans, J. T., Viret, C., & Janeway, C. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00239-5 · Cited by 100 · cited 1×
“Antiinflammatory regulatory T cells have been found to be an important CD4 cell subpopulation for controlling the development of autoimmune disease [12,34,35,36,37,38].”
BackgroundSuryani, S., & Sutton, I. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.023 · Cited by 92
Fernandez‐Martin, A., González‐Rey, E., Chorny, A., Ganea, D., & Delgado, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200535430 · Cited by 83 · cited 2×
“A recent study showed that anti-inflammatory vasoactive intestinal peptide also prevents neurologic progression in MOG-EAE by inducing Treg cell expansion in peripheral lymphoid tissue and the CNS [34].”
BackgroundPonomarev, E. D., Novikova, M., Yassai, M., Szczepanik, M., Gorski, J., & Dittel, B. N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1587 · Cited by 80 · cited 1×
“Proinflammatory cytokines, especially IL-2 and TNF-alpha have been demonstrated to play a significant role in both the induction phase and later clinical stages of EAE pathogenesis [20,21,22].”
BackgroundThe Role of CD8+ T Cells in Multiple Sclerosis and its Animal Models
Goverman, J., Perchellet, A., & Huseby, E. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053586264 · Cited by 76 · cited 2×
“Traditionally CD4 T cells have been considered to be the critical element in EAE pathogenesis, but recent studies have indicated that CD8 cells may also play an important role in EAE induction and disease progression [16,17,18,30].”
BackgroundNegative Selection of T Cells Occurs Throughout Thymic Development
Baldwin, K. K., Trenchak, B. P., Altman, J. D., & Davis, M. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.689 · Cited by 68 · cited 1×
“tolerance [1,2].”
Grasso, G., Sfacteria, A., Passalacqua, M., Morabito, A., Buemi, M., Macrì, B., Brines, M. L., & Tomasello, F. F. (2005) · Neurosurgery · doi:10.1227/01.neu.0000156493.00904.7e · Cited by 67 · cited 2×
“Erythropoietin (EPO), a 165 amino acid glycoprotein cytokine, has been used extensively for the treatment of anemia in humans and has been shown to have the capacity to induce neuroprotection in a disparate variety of animal models of nervous system disease [14,23,24,25].”
BackgroundThe CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Johnson, A. J., Suidan, G. L., Mcdole, J. R., & Pirko, I. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79004-9 · Cited by 62 · cited 1×
“Autoreactive CD4 and CD8 T cells are believed to be involved in the pathogenesis of EAE and MS [15,16,17,18].”
BackgroundCytokine Shifts and Tolerance in Experimental Autoimmune Encephalomyelitis
Chitnis, T., & Khoury, S. J. (2003) · Immunologic Research · doi:10.1385/ir:28:3:223 · Cited by 62 · cited 2×
“Proinflammatory cytokines, especially IL-2 and TNF-alpha have been demonstrated to play a significant role in both the induction phase and later clinical stages of EAE pathogenesis [20,21,22].”
BackgroundMethodHofstetter, H. H., Toyka, K. V., Tary-Lehmann, M., & Lehmann, P. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1372 · Cited by 60 · cited 1×
“The kinetics and organ distribution of Th17 cells in our MOG35–55 induced EAE mice was very similar to the Th17 cell kinetics following proteolipid protein 139–151 peptide induced EAE in SLJ/J mice [39].”
ResultErythropoietin reduces the degree of arthritis caused by type II collagen in the mouse
Cuzzocrea, S., Mazzon, E., di Paola, R., Genovese, T., Patel, N. S. A., Britti, D., de Majo, M., Caputi, A. P., & Thiemermann, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20875 · Cited by 52 · cited 1×
“Beneficial therapeutic effects of exogenously administered whole molecule EPO have been described in several animal models of neurologic injury, including occlusive cerebral vascular disease, acute brain trauma, epilepsy, as well as in both autoimmune arthritis and EAE [14,45,46].”
BackgroundThe role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis
McDole, J., Johnson, A. J., & Pirko, I. (2006) · Neurological Research · doi:10.1179/016164106x98125 · Cited by 52 · cited 1×
“[30,32].”
Sun, D. (2003) · International Immunology · doi:10.1093/intimm/dxg023 · Cited by 51 · cited 4×
“Subcutaneous injection of myelin antigen into animals or adoptive transfer of purified MOG-specific T cells obtained from EAE mice into naı̈ve mice can both induce the disease [18,19].”
BackgroundMethodInfluentialCarbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury
Adembri, C., Massagrande, A., Tani, A., Miranda, M., Margheri, M., Gaudio, R. D., & Pellegrini-Giampietro, D. E. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181644343 · Cited by 47
The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice
Hofstetter, H. H., Karulin, A. Y., Forsthuber, T. G., Ott, P. A., Tary‐Lehmann, M., & Lehmann, P. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.004 · Cited by 41 · cited 2×
“Proinflammatory cytokines, especially IL-2 and TNF-alpha have been demonstrated to play a significant role in both the induction phase and later clinical stages of EAE pathogenesis [20,21,22].”
BackgroundMethodErythropoietin: High Profile, High Scrutiny
Crawford, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8153 · Cited by 41 · cited 1×
“One of the surprising newly recognized consequences of EPO therapy in humans that has emerged over the past several years has been the unexpected negative effect of EPO therapy on survival in cancer patients [51].”
BackgroundTargeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers
Yuan, R. R., Wong, P., McDevitt, M. R., Doubrovina, E., Leiner, I., Bornmann, W., O'Reilly, R., Pamer, E. G., & Scheinberg, D. A. (2004) · Blood · doi:10.1182/blood-2004-01-0324 · Cited by 39 · cited 1×
“immunization. T cells were isolated from the single cell suspensions using MAC pan-T cell beads”
MethodSelf-citation
Research works printed but not linked: 1
- Yuan RR Li W Maeda Y Cook S Dowling P Novel small erythropoietin-derived peptides that retain CNS neuroprotective effects while lacking hematopoietic activity. Ann Neurol 58(5) A20 2005:
Cited by
Advances in islet encapsulation technologies
Desai, T., & Shea, L. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.232 · Cited by 427
Brines, M., & Cerami, A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02024.x · Cited by 333
Animal models of multiple sclerosis—Potentials and limitations
Mix, E., Meyer-Rienecker, H., Hartung, H.-P., & Zettl, U. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.005 · Cited by 210
The pleiotropic effects of erythropoietin in infection and inflammation
Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., & Weiss, G. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.005 · Cited by 161
“Recent studies have characterized EPO as a potent antiinflammatory cytokine in chronic inflammatory disorders and infectious diseases [25,30,36,41].”
BackgroundSargin, D., Friedrichs, H., El-Kordi, A., & Ehrenreich, H. (2010) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2010.10.005 · Cited by 152
Metadata
- Authors
- Yuan, R., Maeda, Y., Li, W., Lu, W., Cook, S., & Dowling, P.
- Affiliations
- VA New Jersey Health Care System (US)
- Corresponding author
- Dowling, Peter
- ORCID
- Maeda, Yasuhiro
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-02
- Volume
- 3
- Issue
- 4
- Pages
- e1924
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2271128
- OpenAlex
- W2044376274
- Cited by
- 94
- References
- 54
- Citations by year
- 2026: 3 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 10 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 7 · 2012: 10
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- National Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- erythropoietin, experimental autoimmune encephalomyelitis, multiple sclerosis, regulatory T cells, Th17 cells, dendritic cells, inflammatory cytokines, neuroinflammation, anti-inflammatory therapy
- MeSH terms
- Animals, Autoimmune Diseases, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Erythropoietin, Genes, MHC Class II, Inflammation, Leukocytes, Mononuclear, Lymph Nodes, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Cytokines, Interleukin-17, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.